Sign in

NCT07376239Completed

Quality of Life, Depression and Sexual Function in Men Living With HIV

Quality of Life, Depression and Sexual Function in Men Living With HIV Under Effective Antiretroviral Therapy Compared With Healthy Controls

Source: ClinicalTrials.gov · Last updated 17 Apr 2026

Brief summary (registry, in English)

This observational case-control study evaluates quality of life, depressive symptoms, and sexual function in heterosexual men living with HIV who are receiving effective combination antiretroviral therapy and have achieved virologic suppression, compared with healthy male controls. Participants complete validated questionnaires assessing quality of life (EUROHIS-QOL-8), depression (Beck Depression Inventory), and sexual function (Arizona Sexual Experience Scale). The study aims to identify psychosocial and sexual health challenges that may persist despite effective HIV treatment.

Status (registry)
Completed
Study type
Observational
Enrollment
99 (actual)
First submitted
21 Jan 2026
Start date
3 Feb 2026
Primary completion date
16 Apr 2026
Lead sponsor
Kocaeli University
Diseases
HIV
NCT number
NCT07376239

What you commit to

  • Study type: Observational
  • Participants enrolled: 99
  • From 3 Feb 2026 to the primary completion date, 16 Apr 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Advanced HIV disease
  • Presence of significant comorbid medical conditions
  • Cognitive impairment or communication difficulties that could interfere with completion of the survey

Age

  • Age \< 18 years

Other

  • Female sex

Who the study is looking for

  • Age ≥ 18 years
  • Male sex
  • Heterosexual orientation
  • Confirmed diagnosis of HIV infection
  • Receiving combination antiretroviral therapy (cART)
  • Virologic suppression confirmed at two consecutive visits
  • Ability to understand and complete the questionnaires

Age in the registry: 18 years to - · Sex: Male · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Kocaeli University
Coordinator of this site? Confirm its status
KocaeliTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.